SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-012190
Filing Date
2018-09-06
Accepted
2018-09-06 16:08:34
Documents
1
Period of Report
2018-09-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6980
  Complete submission text file 0001213900-18-012190.txt   8524
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 63 GREAT ROAD MAYNARD MA 01754
Business Address
Dutia Suren G (Reporting) CIK: 0001514063 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38174 | Film No.: 181057640